$234.98
-0.68 (-0.29%)
USD · as of 2026-08-18 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where CAH is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 interventional
Held by 23 tracked-famous managers (AQR CAPITAL MANAGEMENT LLC, Man Group plc, D. E. Shaw & Co., Inc., RENAISSANCE TECHNOLOGIES LLC, JANE STREET GROUP, LLC, +18 more) · FINRA short interest 3.4 days to cover (settled 2026-07-31) · government filings 180d: 0 congress / 3 executive
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Design Validation Hemodynamic Study of New Kendall SCD SmartFlow Compression SystemNCT05945186Blood VelocityOpen-label · Other | Not applicable | Unknown status | Device: Intermittent Pneumatic Compression (IPC)(Kendall SCD SmartFlow™ compression system with Cardinal Health Element compression sleeves) | Hemodynamics | 19 | Oct 2023 | 2023-07-14 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19